Carmell Therapeutics Corp... (CTCX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.53
7.07%
At close: Jan 13, 2025, 3:00 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 |
Cash & Equivalents | 2.91M | 128.15K | 12.36K |
Short-Term Investments | n/a | n/a | n/a |
Long-Term Investments | n/a | 156.69M | 154.45M |
Other Long-Term Assets | n/a | -156.69M | -154.45M |
Receivables | 204.56K | n/a | n/a |
Inventory | n/a | n/a | n/a |
Other Current Assets | 59.78M | 83.24K | 198.98K |
Total Current Assets | 62.90M | 605.54K | 178.70K |
Property-Plant & Equipment | 1.02M | 1.11M | 1.35M |
Goodwill & Intangibles | 24.19K | 28.70K | 33.22K |
Total Long-Term Assets | 1.05M | 1.14M | 1.38M |
Total Assets | 63.95M | 1.75M | 1.56M |
Account Payables | 4.42M | 2.14M | 871.31K |
Deferred Revenue | n/a | 1.39M | 2.37M |
Short-Term Debt | 1.44M | 2.91M | 8.72M |
Other Current Liabilities | 32.65M | 1.86M | 6.21M |
Total Current Liabilities | 38.50M | 7.30M | 15.80M |
Long-Term Debt | 697.72K | 827.73K | 962.83K |
Other Long-Term Liabilities | n/a | 31.42M | 14.37M |
Total Long-Term Liabilities | 697.72K | 32.24M | 15.33M |
Total Liabilities | 39.20M | 39.54M | 31.13M |
Total Debt | 2.14M | 3.74M | 9.69M |
Common Stock | 2.31K | 14.53K | 36.92K |
Retained Earnings | -58.50M | -42.38M | -32.77M |
Comprehensive Income | n/a | -31.42M | n/a |
Shareholders Equity | 24.75M | -37.79M | -29.58M |
Total Investments | n/a | 156.69M | 154.45M |